Life-threatening hypoglycemia attributable to haloperidol in a patient with schizophrenia

Braz J Psychiatry. 2019 Mar-Apr;41(2):190-191. doi: 10.1590/1516-4446-2018-0356.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Female
  • Haloperidol / adverse effects*
  • Haloperidol / therapeutic use
  • Humans
  • Hypoglycemia / chemically induced*
  • Schizophrenia / drug therapy
  • Severity of Illness Index

Substances

  • Antipsychotic Agents
  • Haloperidol